TNXP · Tonix Pharmaceuticals Holding Corp. · Investor Relations
$5.17
+0.04 (+0.78%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$88.67M
Shares
17.15M
Volume · Oct 23
754.75K
Avg daily vol (3M)
638.76K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-10-21 | World Vaccine Congress Europe 2026 | Event |
| 2026-09-10 | Cantor’s 2026 Global Healthcare Conference | Conference |
| 2026-08-11 | Canaccord Genuity 46th Annual Growth Conference | Conference |
| 2026-08-10 | Second Quarter 2026 Financial Results | Results publication |
| 2026-08-10 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-24 | BIO 2026 International Convention Corporate Presentation | Presentation |
Source: https://ir.tonixpharma.com/
Key facts
CIK
1430306
CUSIP
890260839
13F (30d)
16 filings
16 filers
Visit website
Investor relations